Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
면역 억제를 받는 환자에서 SARS-CoV-2 백신 접종에 대한 체액 및 T 세포 반응
Article
[키워드] antibody
Antibody Response
assays
Autoimmune
Autoimmune diseases
B-cell
B-lymphocytes
BNT162b2
BNT162b2 mRNA
ChAdOx1
ChAdOx1 nCoV-19
ChAdOx1 nCoV-19 vaccines
Combination
COVID-19
detectable
Diseases
Efficacy
Evidence
evidence of
failure
glomerular
glomerular diseases
healthy individuals
immune responses
immunogenic
immunogenicity
Immunological response
Immunosuppression
immunosuppressive
immunosuppressive therapies
immunosuppressive therapy
impair
induce
investigated
Lymphocytes
mounted
non-responder
participant
Patient
preserved
receiving
responders
response
responses
rituximab
robust
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 vaccination
SARS-CoV-2 vaccine
SARS-CoV-2 vaccines
Seroconversion
seroconvert
seroconverted
serological
serology
T-cell ELISpot
T-cell Response
T-cell responses
tacrolimus
therapy
vaccination
Vaccine
vaccine dose
Vaccines
were used
[DOI] 10.1136/annrheumdis-2021-220626 PMC 바로가기 [Article Type] Article
[DOI] 10.1136/annrheumdis-2021-220626 PMC 바로가기 [Article Type] Article